When a hospital's real limit is the number of chemotherapy chairs and nurses, guidelines should favour treatments given by mouth or in fewer, shorter visits, if they work about as well.
Guidelines optimise efficacy and toxicity assuming unlimited delivery capacity. In systems where the chair, nurse, or pharmacy is the constraint, a regimen that is marginally less effective but needs a third of the visits may cure more people because more people get treated at all. Oral capecitabine-based regimens, three-weekly rather than weekly schedules, subcutaneous formulations, and shorter adjuvant durations are candidates. The proposal is a resource-stratified guideline layer that explicitly trades chair-hours against outcome, and trials to fill the evidence gaps.
Shares Fragmented care and guideline gaps, Most of the world has almost no cancer care.
Shares NCCN Guidelines, Most of the world has almost no cancer care.
Shares NCCN Guidelines, Most of the world has almost no cancer care.
Shares Fragmented care and guideline gaps, Cytotoxic chemotherapy.
Shares Fragmented care and guideline gaps, Most of the world has almost no cancer care.
Shares Fragmented care and guideline gaps, Most of the world has almost no cancer care.
Shares Fragmented care and guideline gaps, Most of the world has almost no cancer care.